Caprotec

Technology platform for proteomics research in biopharma

placeBerlin, Berlin, Germany calendar_todayFounded 2007 groups11 employees language caprotec.com

Innovation

1 patent family — focus: Physics & computing; filing pace dormant. Cited 4 times.

YearFilings
20181

Investor mix

6 investors on record; lead investors include Creathor Venture, IBB Beteiligungsgesellschaft, LBBW Venture Capital.

Investor typeCountShare
Venture capital350%
Other / undisclosed350%
Coming soon